{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-013084","form_type":"8-K","ticker":"BBLG","cik":"0001419554","company_name":"Bone Biologics Corp","filed_at":"2025-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.240030+00:00","generated_at":"2026-05-20T04:12:10.006033+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Bone Biologics shareholders approve 30M share increase and 1-for-2.5 to 1-for-10 reverse split","bullets":["Stockholders elected directors Stroever, Angle, Gagnon, and Meikle; all received >90% of votes cast (excluding broker non-votes).","Approved plan amendment increasing authorized shares by 30M to 30,629,489 for equity awards.","Authorized board to implement reverse stock split in range of 1-for-2.5 to 1-for-10 at its discretion.","Ratified Weinberg & Company as auditor for FY2025; advisory say-on-pay passed with 63% support."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-013084","json":"https://secwatch.observer/filing/0001641172-25-013084.json","markdown":"https://secwatch.observer/filing/0001641172-25-013084.md","text":"https://secwatch.observer/filing/0001641172-25-013084.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1419554/000164117225013084/0001641172-25-013084-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1419554/000164117225013084/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T04:12:10.006033+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}